Evidence map›Paper›PMID 41510164›Full record

ArticleTheranostics2026

Precision radiolabeled B-cell maturation nanobody for targeted PET imaging and radioligand therapy of disseminated multiple myeloma.

Behnaz Ghaemi, Colleen P Olkowski, Falguni Basuli, Jianfeng Shi, Ryan Young, Dickran Kazandjian, Ola Landgren, Elizabeth Hill, Peter L Choyke, Orit Jacobson

Abstract read
In one paragraph

Article in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Behnaz GhaemiMolecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA.
Colleen P OlkowskiMolecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA.
Falguni BasuliChemistry and Synthesis Center, National Heart, Lung, and Blood Institute, NIH, Rockville, Maryland, 20850, USA.
Jianfeng ShiChemistry and Synthesis Center, National Heart, Lung, and Blood Institute, NIH, Rockville, Maryland, 20850, USA.
Ryan YoungLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA.
Dickran KazandjianSylvester Myeloma Institute, Sylvester Comprehensive Cancer Center, Department of Medicine, Myeloma Division University of Miami, Florida, 33146, USA.
Ola LandgrenSylvester Myeloma Institute, Sylvester Comprehensive Cancer Center, Department of Medicine, Myeloma Division University of Miami, Florida, 33146, USA.
Elizabeth HillLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA.
Peter L ChoykeMolecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA.
Orit JacobsonMolecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B-Cell Maturation AntigenMultiple MyelomaPositron-Emission TomographySingle-Domain AntibodiesAnimalsCell Line, TumorFemaleHumansIodine RadioisotopesMiceMice, Inbred NODRadiopharmaceuticalsB-Cell Maturation AntigenIodine RadioisotopesRadiopharmaceuticalsSingle-Domain AntibodiesBCMAmultiple myelomananobodyPET imagingradioligand therapytheranostics

Identifiers

PMID41510164
PMCPMC12775650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.